𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cystic fibrosis—cirrhosis, portal hypertension, and liver biopsy: Reply

✍ Scribed by Peter J. Lewindon; Grant A. Ramm

Book ID
102850149
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
632 KB
Volume
53
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis

Shorter duration and lower dose of peginterferon alfa-2a therapy results in inferior HBeAg seroconversion rates compared with the duration and dose of 48 weeks and 180 lg: NEPTUNE study.

📜 SIMILAR VOLUMES

Importance of hepatic fibrosis in cystic
Importance of hepatic fibrosis in cystic fibrosis and the predictive value of liver biopsy
✍ Peter J. Lewindon; Ross W. Shepherd; Meagan J. Walsh; Ristan M. Greer; Richard W 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 294 KB 👁 1 views

Cystic fibrosis liver disease (CFLD), which results from progressive hepatobiliary fibrosis, is an important cause of morbidity and mortality, but it is difficult to identify before portal hypertension (PHT) ensues. Clinical signs, serum alanine aminotransferase (ALT) levels, and ultrasound (US) are

Reply: The utility of noninvasive imagin
Reply: The utility of noninvasive imaging in cystic fibrosis liver disease
✍ Peter J. Lewindon; Grant A. Ramm 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 296 KB 👁 1 views

We read with interest the reviews by Ghouri et al. 1 and Martinez et al. 2 Ghouri et al. analyzed the association of nonalcoholic fatty liver disease (NAFLD) with cardiovascular disease (CVD) and concluded that although a diagnosis of NAFLD should prompt diabetes screening, it is insufficient for co

Effects of verapamil on hepatic and syst
Effects of verapamil on hepatic and systemic hemodynamics and liver function in patients with cirrhosis and portal hypertension
✍ Miquel Navasa; Jaime Bosch; Jürg Reichen; Conxita Bru; Ricardo Mastai; Thomas Zy 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 532 KB

The effects of verapamil on hepatic and systemic hemodynamics and on liver function were investigated in 10 patients with portal hypertension due to advanced micronodular cirrhosis to verify whether, as it has been suggested, this calcium channel blocker may improve liver function and reduce portal